[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE553781T1 - Lineare selbsteliminierende oligomere - Google Patents

Lineare selbsteliminierende oligomere

Info

Publication number
ATE553781T1
ATE553781T1 AT08009514T AT08009514T ATE553781T1 AT E553781 T1 ATE553781 T1 AT E553781T1 AT 08009514 T AT08009514 T AT 08009514T AT 08009514 T AT08009514 T AT 08009514T AT E553781 T1 ATE553781 T1 AT E553781T1
Authority
AT
Austria
Prior art keywords
eliminating
oligomers
linear self
oligomer
self
Prior art date
Application number
AT08009514T
Other languages
English (en)
Inventor
Andre Warnecke
Original Assignee
Ktb Tumorforschungs Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ktb Tumorforschungs Gmbh filed Critical Ktb Tumorforschungs Gmbh
Application granted granted Critical
Publication of ATE553781T1 publication Critical patent/ATE553781T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/555Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
    • A61K47/556Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells enzyme catalyzed therapeutic agent [ECTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/555Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT08009514T 2008-05-23 2008-05-23 Lineare selbsteliminierende oligomere ATE553781T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08009514A EP2123305B1 (de) 2008-05-23 2008-05-23 Lineare selbsteliminierende Oligomere

Publications (1)

Publication Number Publication Date
ATE553781T1 true ATE553781T1 (de) 2012-05-15

Family

ID=39800619

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08009514T ATE553781T1 (de) 2008-05-23 2008-05-23 Lineare selbsteliminierende oligomere

Country Status (4)

Country Link
US (1) US8597631B2 (de)
EP (1) EP2123305B1 (de)
AT (1) ATE553781T1 (de)
WO (1) WO2009141050A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9580553B2 (en) 2012-12-07 2017-02-28 University Of Washington Through Its Center For Commercialization Thermally-activated self-immolative materials
CN112043835B (zh) * 2013-12-06 2022-10-21 韩捷 用于含氮和羟基的药物的生物可逆引入基团
WO2017129818A1 (de) * 2016-01-29 2017-08-03 Humboldt-Universität Zu Berlin Linkermolekül und verwendung desselben in verfahren zur reinigung von peptiden
CN112638864B (zh) * 2018-08-27 2024-03-08 格瑞罗斯普罗泰恩科技公司 用于肽纯化的无痕还原性可裂解接头分子
CN113929599B (zh) * 2020-07-08 2022-07-15 中国科学技术大学 一种精确嵌段聚合物纳米组装体及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2506080A1 (en) * 2002-11-14 2004-05-27 Syntarga B.V. Prodrugs built as multiple self-elimination-release spacers
US20060269480A1 (en) * 2005-05-31 2006-11-30 Ramot At Tel Aviv University Ltd. Multi-triggered self-immolative dendritic compounds
WO2008053479A1 (en) * 2006-10-30 2008-05-08 Ramot At Tel Aviv University Ltd. Self-immolative polymers

Also Published As

Publication number Publication date
US8597631B2 (en) 2013-12-03
WO2009141050A2 (en) 2009-11-26
EP2123305A1 (de) 2009-11-25
WO2009141050A3 (en) 2010-01-14
EP2123305B1 (de) 2012-04-18
US20120270937A1 (en) 2012-10-25

Similar Documents

Publication Publication Date Title
BRPI0816104A2 (pt) Produtos de lentes de contato.
BRPI0809829A2 (pt) Composição, artigo e embalagem
DE602006020277D1 (de) Warenverpackung
NO20081160L (no) Benzimidazoltiofen forbindelser
NL2001268A1 (nl) Artikeltransportmiddel.
NL2000997A1 (nl) Artikeltransportmiddel.
NL1031912A1 (nl) Gestapeld ontlaatsysteem.
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
ATE553781T1 (de) Lineare selbsteliminierende oligomere
CL2007002812A1 (es) Compuestos derivados de quinolina; composicion farmaceutica, utiles para inhibir el vih.
SI2012701T1 (sl) Odstranljiva embalaža za sterilizacijo
EP2151463A3 (de) Alkylierte aminoproyliertes Methylen-di-(cyclohexylamin) und Verwendungen davon
CY1117599T1 (el) Σουλφοναμιδια για την προληψη του διαβητη
NO20091386L (no) Fenyloksyanilinderivater
CY1110787T1 (el) Νεα μορφινικα παραγωγα
JP2006176755A5 (de)
NO20084671L (no) Peptidforbindelse med biologisk aktivite, dets tillaging og dets anvedelser
FI7398U1 (fi) Kantoelin, pakkausaihio ja kantopakkaus
UA13006S (uk) Етикетка для томатної продукції
ITBO20060704A1 (it) Carrello per dispositivi di confezionamento.
UA15789S (uk) Контейнер транспортний кт-2,0
ITTO20050015U1 (it) Oggetto promozionale, particolarmente articolo di cartoleria.
ITRM20080033U1 (it) Confezione per articoli.
NO20053924D0 (no) Emballasje.
ES1059782Y (es) Embalaje expositor para botellas.